Tags

Type your tag names separated by a space and hit enter

Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule.
Fed Regist. 2000 Aug 29; 65(168):52302-5.FR

Abstract

The Food and Drug Administration (FDA) is issuing a final rule amending the monograph for over-the-counter (OTC) topical antifungal drug products. The amendment makes a minor change in the indications for these drug products. This final rule is part of the ongoing review of OTC drug products conducted by FDA.

MeSH

Administration, TopicalAntifungal AgentsHumansNonprescription DrugsProduct LabelingUnited StatesUnited States Food and Drug Administration

Pub Type(s)

Journal Article

Language

eng

PubMed ID

11067736

Citation

"Topical Antifungal Drug Products for Over-the-counter Human Use; Amendment of Final Monograph. Food and Drug Administration, HHS. Final Rule." Federal Register, vol. 65, no. 168, 2000, pp. 52302-5.
Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule. Fed Regist. 2000;65(168):52302-5.
(2000). Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule. Federal Register, 65(168), 52302-5.
Topical Antifungal Drug Products for Over-the-counter Human Use; Amendment of Final Monograph. Food and Drug Administration, HHS. Final Rule. Fed Regist. 2000 Aug 29;65(168):52302-5. PubMed PMID: 11067736.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule. PY - 2000/11/7/pubmed PY - 2000/11/7/medline PY - 2000/11/7/entrez SP - 52302 EP - 5 JF - Federal register JO - Fed Regist VL - 65 IS - 168 N2 - The Food and Drug Administration (FDA) is issuing a final rule amending the monograph for over-the-counter (OTC) topical antifungal drug products. The amendment makes a minor change in the indications for these drug products. This final rule is part of the ongoing review of OTC drug products conducted by FDA. SN - 0097-6326 UR - https://www.unboundmedicine.com/medline/citation/11067736/Topical_antifungal_drug_products_for_over_the_counter_human_use DB - PRIME DP - Unbound Medicine ER -